Artificial Intelligence, Open Source, Drug Discovery, Malaria.
still far for many organizations, with the main barriers being lack of expertise, benchmarks and trust. Increase in AI/ML-related publications vs perceived barriers for its adoption in science. Undoubtedly, the novelty of the technology and the lack of thorough validations has prevented a faster